For the quarter ending 2025-09-30, SIBN had -$7,663K decrease in cash & cash equivalents over the period. -$620K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -4,566 | -12,694 |
| Stock-based compensation | 6,226 | 13,321 |
| Depreciation and amortization | 1,486 | 2,646 |
| Accounts receivable credit losses | 62 | 475 |
| Amortization of discount and premium on marketable securities | 700 | 1,740 |
| Inventory reserve | 549 | 1,235 |
| Amortization of debt issuance costs | 29 | 59 |
| Loss on disposal of property and equipment | -814 | -628 |
| Accounts receivable | 2,234 | -2,598 |
| Inventory | 2,042 | 8,292 |
| Prepaid expenses and other assets | -512 | 93 |
| Accounts payable | 662 | 583 |
| Accrued liabilities and other | 1,537 | -3,464 |
| Net cash used in operating activities | 2,335 | -4,738 |
| Maturities of marketable securities | 52,000 | 104,100 |
| Purchases of marketable securities | 59,070 | 98,770 |
| Purchases of property and equipment | 2,955 | 4,171 |
| Net cash (used in) provided by investing activities | -10,025 | 1,159 |
| Proceeds from issuance of common stock under employee stock purchase plan | 0 | 1,568 |
| Proceeds from the exercise of stock options | 11 | 768 |
| Net cash provided by financing activities | 11 | 2,336 |
| Effect of exchange rate changes on cash and cash equivalents | 16 | 445 |
| Net decrease in cash and cash equivalents | -7,663 | -798 |
| Cash and cash equivalents at beginning of period | 34,948 | - |
| Cash and cash equivalents at end of period | 26,487 | - |
SI-BONE, Inc. (SIBN)
SI-BONE, Inc. (SIBN)